Literature DB >> 9573225

Loss of CD4+ T cells in human immunodeficiency virus type 1-infected chimpanzees is associated with increased lymphocyte apoptosis.

I C Davis1, M Girard, P N Fultz.   

Abstract

Supportive evidence that apoptosis contributes to loss of CD4+ lymphocytes in human immunodeficiency virus type 1 (HIV-1)-infected humans comes from an apparent lack of abnormal apoptosis in apathogenic lentivirus infections of nonhuman primates, including HIV-1 infection of chimpanzees. Two female chimpanzees were inoculated, one cervically and the other intravenously, with HIV-1 derived from the LAI/LAV-1b strain, which was isolated from a chimpanzee infected with the virus for 8 years. Within 6 weeks of infection, both recipient chimpanzees developed a progressive loss of CD4+ T cells which correlated with persistently high viral burdens and increased levels of CD4+ T-cell apoptosis both in vitro and in vivo. Lymph nodes from both animals also revealed evidence of immune hyperactivation. Intermediate levels of T-cell apoptosis in both peripheral blood and lymph nodes were seen in a third chimpanzee that had been infected with the LAI/LAV-1b strain for 9 years; this animal has maintained depressed CD4/CD8 T-cell ratios for the last 3 years. Similar analyses of cells from 4 uninfected animals and 10 other HIV-1-infected chimpanzees without loss of CD4+ cells revealed no difference in levels of apoptosis in these two control groups. These results demonstrate a correlation between immune hyperactivation, T-cell apoptosis, and chronic loss of CD4+ T cells in HIV-1-infected chimpanzees, providing additional evidence that apoptosis is an important factor in T-cell loss in AIDS. Furthermore, the results show that some HIV-1 strains are pathogenic for chimpanzees and that this species is not inherently resistant to HIV-1-induced disease.

Entities:  

Mesh:

Year:  1998        PMID: 9573225      PMCID: PMC109978          DOI: 10.1128/JVI.72.6.4623-4632.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

Review 1.  From cell activation to cell depletion. The programmed cell death hypothesis of AIDS pathogenesis.

Authors:  J C Ameisen
Journal:  Adv Exp Med Biol       Date:  1995       Impact factor: 2.622

2.  Frequency of provirus-bearing CD4+ cells in HIV type 1 infection correlates with extent of in vitro apoptosis of CD8+ but not of CD4+ cells.

Authors:  M Carbonari; M Cibati; A M Pesce; D Sbarigia; P Grossi; G D'Offizi; G Luzi; M Fiorilli
Journal:  AIDS Res Hum Retroviruses       Date:  1995-07       Impact factor: 2.205

Review 3.  New concepts in the immunopathogenesis of HIV infection.

Authors:  G Pantaleo; A S Fauci
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

4.  Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein.

Authors:  C J Li; D J Friedman; C Wang; V Metelev; A B Pardee
Journal:  Science       Date:  1995-04-21       Impact factor: 47.728

5.  Immunohistopathology of lymph nodes in HTLV-III infected homosexuals with persistent adenopathy or AIDS.

Authors:  P Biberfeld; A Porwit-Ksiazek; B Böttiger; L Morfeldt-Månsson; G Biberfeld
Journal:  Cancer Res       Date:  1985-09       Impact factor: 12.701

6.  Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes.

Authors:  T H Finkel; G Tudor-Williams; N K Banda; M F Cotton; T Curiel; C Monks; T W Baba; R M Ruprecht; A Kupfer
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

7.  Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.

Authors:  M O Westendorp; R Frank; C Ochsenbauer; K Stricker; J Dhein; H Walczak; K M Debatin; P H Krammer
Journal:  Nature       Date:  1995-06-08       Impact factor: 49.962

8.  Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion.

Authors:  J W Mellors; L A Kingsley; C R Rinaldo; J A Todd; B S Hoo; R P Kokka; P Gupta
Journal:  Ann Intern Med       Date:  1995-04-15       Impact factor: 25.391

9.  Apoptosis-related mortality in vitro of mononuclear cells from patients with HIV infection correlates with disease severity and progression.

Authors:  F Pandolfi; M Pierdominici; A Oliva; G D'Offizi; I Mezzaroma; B Mollicone; A Giovannetti; L Rainaldi; I Quinti; F Aiuti
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-08-15

10.  Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals.

Authors:  P D Katsikis; E S Wunderlich; C A Smith; L A Herzenberg; L A Herzenberg
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

View more
  16 in total

1.  Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees.

Authors:  T Beaumont; S Broersen; A van Nuenen; H G Huisman; A M de Roda Husman; J L Heeney; H Schuitemaker
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Bystander killing during avian leukosis virus subgroup B infection requires TVB(S3) signaling.

Authors:  Felipe Diaz-Griffero; Steven A Hoschander; Jürgen Brojatsch
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 3.  Is the high virulence of HIV-1 an unfortunate coincidence of primate lentiviral evolution?

Authors:  Frank Kirchhoff
Journal:  Nat Rev Microbiol       Date:  2009-03-23       Impact factor: 60.633

4.  Differential selection of specific human immunodeficiency virus type 1/JC499 variants after mucosal and parenteral inoculation of chimpanzees.

Authors:  Qing Wei; Patricia N Fultz
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  T cell interleukin-15 surface expression in chimpanzees infected with human immunodeficiency virus.

Authors:  Annette R Rodriguez; Vida Hodara; Kruthi Murthy; LaShayla Morrow; Melissa Sanchez; Amy E Bienvenu; Krishna K Murthy
Journal:  Cell Immunol       Date:  2014-02-06       Impact factor: 4.868

6.  Rapid CD4(+) T-cell loss induced by human immunodeficiency virus type 1(NC) in uninfected and previously infected chimpanzees.

Authors:  F J Novembre; J de Rosayro; S Nidtha; S P O'Neil; T R Gibson; T Evans-Strickfaden; C E Hart; H M McClure
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

7.  Viral dynamics model with CTL immune response incorporating antiretroviral therapy.

Authors:  Yan Wang; Yicang Zhou; Fred Brauer; Jane M Heffernan
Journal:  J Math Biol       Date:  2012-08-29       Impact factor: 2.259

8.  Virus-specific cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected chimpanzees.

Authors:  S Santra; P N Fultz; N L Letvin
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

9.  Effects of antiretroviral drugs on human immunodeficiency virus type 1-induced CD4(+) T-cell death.

Authors:  Jérôme Estaquier; Jean-Daniel Lelièvre; Frédéric Petit; Thomas Brunner; Laure Moutouh-De Parseval; Douglas D Richman; Jean Claude Ameisen; Jacques Corbeil
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

10.  Distinct cycling CD4(+)- and CD8(+)-T-cell profiles during the asymptomatic phase of simian immunodeficiency virus SIVmac251 infection in rhesus macaques.

Authors:  V Monceaux; R Ho Tsong Fang; M C Cumont; B Hurtrel; J Estaquier
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.